Canuso相关文献与解析，生知库 | 链接生命科学的每一步

Janik, Adam; Qiu, Xin; Lane, Rosanne; Popova, Vanina; Drevets, Wayne C; Canuso, Carla M; Macaluso, Matthew; Mattingly, Gregory W; Shelton, Richard C; Zajecka, John M; Fu, Dong-Jing

抑郁症

神经科学

发表日期：2025

文献求助收藏

Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controlled study

一项II期随机、双盲、安慰剂对照研究的结果显示，κ受体拮抗剂阿替卡仑作为口服SSRI/SNRI类抗抑郁药的辅助治疗，对重度抑郁症的疗效和安全性具有重要意义。

期刊:Neuropsychopharmacology

影响因子:7.1

doi:10.1038/s41386-024-01862-x

Schmidt, Mark E; Kezic, Iva; Popova, Vanina; Melkote, Rama; Van Der Ark, Peter; Pemberton, Darrel J; Mareels, Guy; Canuso, Carla M; Fava, Maurizio; Drevets, Wayne C

Efficacy and safety of JNJ-42165279, a fatty acid amide hydrolase inhibitor, in adolescents and adults with autism spectrum disorder: a randomized, phase 2, placebo-controlled study

脂肪酸酰胺水解酶抑制剂 JNJ-42165279 在自闭症谱系障碍青少年和成人患者中的疗效和安全性：一项随机、II 期、安慰剂对照研究

期刊:Neuropsychopharmacology

影响因子:7.1

doi:10.1038/s41386-024-02001-2

Klein, Matthew E; Bangerter, Abigail; Halter, Robin J; Cooper, Kim; Aguilar, Zuleima; Canuso, Carla M; Drevets, Wayne C; Schmidt, Mark E; Pandina, Gahan

Genome-wide association study meta-analysis of suicide death and suicidal behavior

全基因组关联研究荟萃分析：自杀死亡与自杀行为

期刊:Molecular Psychiatry

影响因子:10.1

doi:10.1038/s41380-022-01828-9

Li, Qingqin S; Shabalin, Andrey A; DiBlasi, Emily; Gopal, Srihari; Canuso, Carla M; Palotie, Aarno; Drevets, Wayne C; Docherty, Anna R; Coon, Hilary

发表日期：2023

文献求助收藏

Comments to Drs Taillefer de Laportalière, Jullien, Yrondi, Cestac, and Montastruc

对 Taillefer de Laportalière、Jullien、Yrondi、Cestac 和 Montastruc 博士的评论

期刊:Psychological Medicine

影响因子:5.5

doi:10.1017/S0033291723002490

Fu, Dong-Jing; Bossie, Cynthia A; Lane, Rosanne; Janik, Adam; Canuso, Carla M; Drevets, Wayne C

发表日期：2023

文献求助收藏

Commentary on Cochrane review: "Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder"

对 Cochrane 综述的评论：“氯胺酮和其他谷氨酸受体调节剂治疗成人单相重度抑郁症”

期刊:Journal of Psychopharmacology

影响因子:5.5

doi:10.1177/02698811221123046

Borentain, Stephane; Desai, Pooja; Fu, Dong-Jing; Nancy Chen, Li; Lane, Rosanne; Mathews, Maju; Canuso, Carla M

Smart manufacturing inspired approach to research, development, and scale-up of electrified chemical manufacturing systems

智能制造理念启发了电气化化学制造系统的研究、开发和规模化应用。

期刊:iScience

影响因子:4.1

doi:10.1016/j.isci.2023.106966

Richard, Derek; Jang, Joonbaek; Çıtmacı, Berkay; Luo, Junwei; Canuso, Vito; Korambath, Prakashan; Morales-Leslie, Olivia; Davis, James F; Malkani, Haresh; Christofides, Panagiotis D; Morales-Guio, Carlos G

发表日期：2023

文献求助收藏

Esketamine versus placebo on time to remission in major depressive disorder with acute suicidality

艾司氯胺酮与安慰剂治疗伴有急性自杀倾向的重度抑郁症缓解时间的比较

期刊:BMC Psychiatry

影响因子:3.6

doi:10.1186/s12888-023-05017-y

Fu, Dong-Jing; Zhang, Qiaoyi; Shi, Ling; Borentain, Stephane; Guo, Shien; Mathews, Maju; Anjo, Joana; Nash, Abigail I; O'Hara, Marguerite; Canuso, Carla M

Effects of esketamine on patient-reported outcomes in major depressive disorder with active suicidal ideation and intent: a pooled analysis of two randomized phase 3 trials (ASPIRE I and ASPIRE II)

艾司氯胺酮对伴有自杀意念和意图的重度抑郁症患者报告结局的影响：两项随机3期试验（ASPIRE I 和 ASPIRE II）的汇总分析

期刊:Quality of Life Research

影响因子:2.7

doi:10.1007/s11136-023-03451-9

Jamieson, Carol; Canuso, Carla M; Ionescu, Dawn F; Lane, Rosanne; Qiu, Xin; Rozjabek, Heather; Molero, Patricio; Fu, Dong-Jing

Suicide-specific mortality among patients with treatment-resistant major depressive disorder, major depressive disorder with prior suicidal ideation or suicide attempts, or major depressive disorder alone

难治性重度抑郁症患者、既往有自杀意念或自杀未遂史的重度抑郁症患者以及单纯重度抑郁症患者的自杀特异性死亡率

期刊:Brain and Behavior

影响因子:2.7

doi:10.1002/brb3.3171

Kern, David M; Canuso, Carla M; Daly, Ella; Johnson, Jonathan C; Fu, Dong Jing; Doherty, Teodora; Blauer-Peterson, Cori; Cepeda, M Soledad

Esketamine Monotherapy in Adults With Treatment-Resistant Depression: A Randomized Clinical Trial

艾司氯胺酮单药治疗成人难治性抑郁症：一项随机临床试验

Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controlled study

一项II期随机、双盲、安慰剂对照研究的结果显示，κ受体拮抗剂阿替卡仑作为口服SSRI/SNRI类抗抑郁药的辅助治疗，对重度抑郁症的疗效和安全性具有重要意义。

Efficacy and safety of JNJ-42165279, a fatty acid amide hydrolase inhibitor, in adolescents and adults with autism spectrum disorder: a randomized, phase 2, placebo-controlled study

脂肪酸酰胺水解酶抑制剂 JNJ-42165279 在自闭症谱系障碍青少年和成人患者中的疗效和安全性：一项随机、II 期、安慰剂对照研究

Genome-wide association study meta-analysis of suicide death and suicidal behavior

全基因组关联研究荟萃分析：自杀死亡与自杀行为

Comments to Drs Taillefer de Laportalière, Jullien, Yrondi, Cestac, and Montastruc

对 Taillefer de Laportalière、Jullien、Yrondi、Cestac 和 Montastruc 博士的评论

Commentary on Cochrane review: "Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder"

对 Cochrane 综述的评论：“氯胺酮和其他谷氨酸受体调节剂治疗成人单相重度抑郁症”

Smart manufacturing inspired approach to research, development, and scale-up of electrified chemical manufacturing systems

智能制造理念启发了电气化化学制造系统的研究、开发和规模化应用。

Esketamine versus placebo on time to remission in major depressive disorder with acute suicidality

艾司氯胺酮与安慰剂治疗伴有急性自杀倾向的重度抑郁症缓解时间的比较

Effects of esketamine on patient-reported outcomes in major depressive disorder with active suicidal ideation and intent: a pooled analysis of two randomized phase 3 trials (ASPIRE I and ASPIRE II)

艾司氯胺酮对伴有自杀意念和意图的重度抑郁症患者报告结局的影响：两项随机3期试验（ASPIRE I 和 ASPIRE II）的汇总分析

Suicide-specific mortality among patients with treatment-resistant major depressive disorder, major depressive disorder with prior suicidal ideation or suicide attempts, or major depressive disorder alone

难治性重度抑郁症患者、既往有自杀意念或自杀未遂史的重度抑郁症患者以及单纯重度抑郁症患者的自杀特异性死亡率

Esketamine Monotherapy in Adults With Treatment-Resistant Depression: A Randomized Clinical Trial

艾司氯胺酮单药治疗成人难治性抑郁症：一项随机临床试验

Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controlled study

一项II期随机、双盲、安慰剂对照研究的结果显示，κ受体拮抗剂阿替卡仑作为口服SSRI/SNRI类抗抑郁药的辅助治疗，对重度抑郁症的疗效和安全性具有重要意义。

Efficacy and safety of JNJ-42165279, a fatty acid amide hydrolase inhibitor, in adolescents and adults with autism spectrum disorder: a randomized, phase 2, placebo-controlled study

脂肪酸酰胺水解酶抑制剂 JNJ-42165279 在自闭症谱系障碍青少年和成人患者中的疗效和安全性：一项随机、II 期、安慰剂对照研究

Genome-wide association study meta-analysis of suicide death and suicidal behavior

全基因组关联研究荟萃分析：自杀死亡与自杀行为

Comments to Drs Taillefer de Laportalière, Jullien, Yrondi, Cestac, and Montastruc

对 Taillefer de Laportalière、Jullien、Yrondi、Cestac 和 Montastruc 博士的评论

Commentary on Cochrane review: "Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder"

对 Cochrane 综述的评论：“氯胺酮和其他谷氨酸受体调节剂治疗成人单相重度抑郁症”

Smart manufacturing inspired approach to research, development, and scale-up of electrified chemical manufacturing systems

智能制造理念启发了电气化化学制造系统的研究、开发和规模化应用。

Esketamine versus placebo on time to remission in major depressive disorder with acute suicidality

艾司氯胺酮与安慰剂治疗伴有急性自杀倾向的重度抑郁症缓解时间的比较

Effects ﻿of esketamine on patient-reported outcomes in major depressive disorder with active suicidal ideation and intent: a pooled analysis of two randomized phase 3 trials (ASPIRE I and ASPIRE II)

艾司氯胺酮对伴有自杀意念和意图的重度抑郁症患者报告结局的影响：两项随机3期试验（ASPIRE I 和 ASPIRE II）的汇总分析

Suicide-specific mortality among patients with treatment-resistant major depressive disorder, major depressive disorder with prior suicidal ideation or suicide attempts, or major depressive disorder alone

难治性重度抑郁症患者、既往有自杀意念或自杀未遂史的重度抑郁症患者以及单纯重度抑郁症患者的自杀特异性死亡率

Effects of esketamine on patient-reported outcomes in major depressive disorder with active suicidal ideation and intent: a pooled analysis of two randomized phase 3 trials (ASPIRE I and ASPIRE II)